Bartlett & Co’s Phibro Animal Health PAHC Stock Holding History

Bartlett & Co’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21	Closed	–	–	733
2021 Q3	$0	Buy	+21	New	+$505	﹤0.01%	1030

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bartlett & Co's PAHC Position: Q4 2021 in Review

Bartlett & Co sold out of Phibro Animal Health (PAHC) in Q4 2021, closing a stake of 21 shares.

Bartlett & Co first reported a position in PAHC in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 145 funds tracked by Wall St. Rank hold PAHC as of Q4 2021.

Bartlett & Co reported no remaining Phibro Animal Health position as of Q4 2021 after selling out during the quarter.
Bartlett & Co sold 21 Phibro Animal Health shares in Q4 2021.
Bartlett & Co first reported a position in Phibro Animal Health in Q3 2021 and held it in 1 quarter.
Bartlett & Co's Phibro Animal Health position peaked at $0 in Q3 2021.
145 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2021.

Based on Bartlett & Co's 13F filing for Q4 2021, filed 8 Mar 2022.